Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-25 @ 11:21 PM
Study NCT ID:
NCT00932893
Status:
COMPLETED
Last Update Posted:
2017-01-02
First Post:
2009-06-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2012-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-06-30
First Submit QC Date:
None
Study First Post Date:
2009-07-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-03-13
Results First Submit QC Date:
None
Results First Post Date:
2013-06-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-31
Last Update Post Date:
2017-01-02
Last Update Post Date Type:
ESTIMATED